Literature DB >> 12418475

Attitude of Czech physicians to adverse drug reaction reporting.

F Perlík1, O Slanar, M Smíd, J Petrácek.   

Abstract

This survey was carried out to test physicians' knowledge of the principles of adverse drug reaction (ADR) reporting. Structured interviews were carried out with 500 physicians in all regions of the Czech Republic. The questions were aimed at observing ADR, the obligation and the means of reporting, and the source of drug information used in practice. Ninety percent (n=448) reported that they faced ADR in their practice, and 92% (n=458) were aware of the obligation to report, but most (180 general practitioners, 138 specialists) were unclear as to what should be reported. Knowledge of the subject of ADR reporting was significantly lower (18.4%) among physicians who used primarily the drug information provided by pharmaceutical companies than among those who used other information sources (38.4%). The low level of knowledge of ADR spontaneous reporting system found in our study is one of the reasons for the substantial underreporting of ADR in the Czech Republic compared to other European countries.

Entities:  

Mesh:

Year:  2002        PMID: 12418475     DOI: 10.1007/s00228-002-0476-z

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  4 in total

1.  A survey of the knowledge, attitude and practice of adverse drug reaction reporting by clinicians in eastern India.

Authors:  Suparna Chatterjee; Nazmun Lyle; Souvik Ghosh
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

2.  A small economic inducement to stimulate increased reporting of adverse drug reactions--a way of dealing with an old problem?

Authors:  M Bäckström; T Mjörndal
Journal:  Eur J Clin Pharmacol       Date:  2006-03-30       Impact factor: 2.953

Review 3.  Determinants of under-reporting of adverse drug reactions: a systematic review.

Authors:  Elena Lopez-Gonzalez; Maria T Herdeiro; Adolfo Figueiras
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

4.  Adverse drug reaction reporting in the Czech Republic 2005-2009.

Authors:  Eva Kopečná; Veronika Deščíková; Jiří Vlček; Jana Mladá
Journal:  Int J Clin Pharm       Date:  2011-06-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.